Third, cardiovascular disease involves an increased risk of in-hospital death in COVID-19, which might be mediated by ACE2-dependent myocardial infection [49] or the high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias [50]. Here, ACE2 is linked to chronic obstructive pulmonary disease.